Section II:New Technologies and New Products——Session 3:New Breakthroughs in HMOs Precision Nutrition and Its Diversified Population Applications |
2026-03-14 08:30-11:40 Dongyu,Yiyong room(Wanquan Ballroom 1/3) |
Moderators: |
| 2026-03-14 08:30-08:50 Chinese HMOs Profile:Research and Application |
| 2026-03-14 08:50-09:10 Regulatory Effects of HMOs on Glucose and Lipid Metabolism Disorders in Adults |
| 2026-03-14 09:10-09:30 The trends of regulatory management of HMOs |
| 2026-03-14 09:30-09:50 The Potential Application Value of HMOs in the Field of Healthy Aging |
| 2026-03-14 09:50-10:10 Protective and Mitigative Effects of HMO Combined with Probiotics on Necrotizing EnterocolitisCapitolab |
| 2026-03-14 10:10-10:30 The Effects of Multiple Human Milk Oligosaccharides and HMO-Based Combinations on Infant/Toddler Health and Neurocognitive Development:Evidence-Based Research and Future Innovation Pathways |
| 2026-03-14 10:30-10:50 Unlocking the Health Code of HMOs:Clinical Research Exploration and Practice by Synaura Bio |
| 2026-03-14 10:50-11:10 Global Trends in HMO Research and Applications |
| 2026-03-14 11:10-11:40 Roundtable Meeting：Risks of Biosynthetic Human Milk Oligosaccharides (HMOs) Applied in the Production of Infant and Toddler Formula Milk Powder |
